Risk stratification of cardiogenic cerebral embolism using serological parameters, and efficacy and safety of pharmacological and non-pharmacological treatment: prospective study

Risk stratification of cardiogenic cerebral embolism using serological parameters, and efficacy and safety of pharmacological and non-pharmacological treatment: prospective study - Prospective study of risk stratification of cardiogenic cerebral embolism using serological parameters

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020636

Enrollment

400

Registered

2016-01-19

Start date

2014-07-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with atrial fibrillation

Exclusion criteria

Exclusion criteria: (1) patients who could not receive anticoagulation (2) patients with severely impaired renal function (3) patients with absolute indication for warfarin (4) patients who are considered as ineligible for this study by attending physician

Design outcomes

Primary

Measure	Time frame
death, cerebral infarction, bleeding complication	—

Countries

Japan

Contacts

Public ContactKoji Miyamoto

National Cerebral and Cardiovascular Center Department of Cardiovascular Medicine

kojimiya@hsp.ncvc.go.jp06-6833-5012

Outcome results